KR920006881B1 - 프리파스타틴(plipastatin)의 제조방법 - Google Patents

프리파스타틴(plipastatin)의 제조방법 Download PDF

Info

Publication number
KR920006881B1
KR920006881B1 KR1019850009104A KR850009104A KR920006881B1 KR 920006881 B1 KR920006881 B1 KR 920006881B1 KR 1019850009104 A KR1019850009104 A KR 1019850009104A KR 850009104 A KR850009104 A KR 850009104A KR 920006881 B1 KR920006881 B1 KR 920006881B1
Authority
KR
South Korea
Prior art keywords
prepastatin
present
plipastatin
strain
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850009104A
Other languages
English (en)
Korean (ko)
Other versions
KR860005027A (ko
Inventor
하마오 우메자와
다까아끼 아오야기
도미오 다께우찌
마사 하마다
히로시 나가나와
야스히꼬 무라오까
다까아끼 니시끼오리
Original Assignee
자이단 호오진 비세이부쓰 가가꾸 겡뀨우가이
이찌가와 도꾸지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 자이단 호오진 비세이부쓰 가가꾸 겡뀨우가이, 이찌가와 도꾸지 filed Critical 자이단 호오진 비세이부쓰 가가꾸 겡뀨우가이
Publication of KR860005027A publication Critical patent/KR860005027A/ko
Application granted granted Critical
Publication of KR920006881B1 publication Critical patent/KR920006881B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
KR1019850009104A 1984-12-06 1985-12-04 프리파스타틴(plipastatin)의 제조방법 Expired KR920006881B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59256475A JPS61134398A (ja) 1984-12-06 1984-12-06 新生理活性物質プリパスタチン及びその製造法
JP84-256475 1984-12-06

Publications (2)

Publication Number Publication Date
KR860005027A KR860005027A (ko) 1986-07-16
KR920006881B1 true KR920006881B1 (ko) 1992-08-21

Family

ID=17293148

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850009104A Expired KR920006881B1 (ko) 1984-12-06 1985-12-04 프리파스타틴(plipastatin)의 제조방법

Country Status (13)

Country Link
US (1) US4742155A (https=)
EP (1) EP0192828B1 (https=)
JP (1) JPS61134398A (https=)
KR (1) KR920006881B1 (https=)
AT (1) ATE63318T1 (https=)
AU (1) AU583553B2 (https=)
DE (1) DE3582791D1 (https=)
DK (1) DK564785A (https=)
ES (1) ES8701197A1 (https=)
GR (1) GR852894B (https=)
HU (1) HU193838B (https=)
PT (1) PT81615B (https=)
ZA (1) ZA859315B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
IN167138B (https=) * 1988-08-17 1990-09-01 Hoechst India
US5619066A (en) * 1990-05-15 1997-04-08 Dallas Semiconductor Corporation Memory for an electronic token
DE69229173T2 (de) * 1991-07-04 1999-09-16 Garvan Institute Of Medical Research, Darlinghurst Pla2 hemmende verbindungen
PL198772B1 (pl) * 1997-05-09 2008-07-31 Agraquest Biologicznie czysta kultura Bacillus subtilis, jej metabolit i supernatant z hodowli szczepu, kompozycje do ochrony roślin i owoców przed szkodnikami, sposób ochrony lub leczenia roślin i owoców, agrastatyny, sposób izolowania supernatantu o aktywności owadobójczej
CN117683074B (zh) * 2023-12-13 2024-08-16 山东绿邦生物科技有限公司 蜡样芽孢杆菌、蛋白酶抑制剂以及提高蛋白渣产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F

Also Published As

Publication number Publication date
ZA859315B (en) 1986-10-29
ES8701197A1 (es) 1986-11-16
HUT40707A (en) 1987-01-28
JPS61134398A (ja) 1986-06-21
US4742155A (en) 1988-05-03
EP0192828B1 (en) 1991-05-08
KR860005027A (ko) 1986-07-16
EP0192828A3 (en) 1988-06-01
EP0192828A2 (en) 1986-09-03
GR852894B (https=) 1986-04-01
ES549565A0 (es) 1986-11-16
HU193838B (en) 1987-12-28
DK564785A (da) 1986-06-07
PT81615B (pt) 1988-02-17
AU583553B2 (en) 1989-05-04
DK564785D0 (da) 1985-12-05
ATE63318T1 (de) 1991-05-15
PT81615A (en) 1986-01-01
DE3582791D1 (de) 1991-06-13
AU5030785A (en) 1986-06-12

Similar Documents

Publication Publication Date Title
US4990448A (en) Bu-4061T
DE69222142T2 (de) Neuartige prolyl-endopeptidase-inhibitoren sna-115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
US5071957A (en) Antibiotic BU-4061T
KR920006881B1 (ko) 프리파스타틴(plipastatin)의 제조방법
US5643869A (en) Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
US6013627A (en) Organic compounds
US4742047A (en) Semi-synthetic peptide antibiotics
KR100997073B1 (ko) 멤노 펩타이드, 이의 제조방법 및 이를 포함하는 약제학적 조성물
NZ224341A (en) Glycopeptides having enkephalinase inhibiting properties (enkastins)
EP1136488A1 (en) Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
US5648455A (en) Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
DE69604385T2 (de) Isocumarine mit antitumorwirkung
AU752169B2 (en) Macrolides with antitumor activity
NZ544066A (en) New cytotoxic depsipeptides
JP3786461B2 (ja) 新生理活性物質
JP3830964B2 (ja) 海洋放線菌から単離した新規なチオデプシペプチド
EP0677513B1 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use
JP2810752B2 (ja) 新規生理活性物質サイクロオクタチン、その製造法およびその用途
US6025466A (en) Cyclic hepta-peptide derivative from colonial ascidians, Lissoclinum sp.
KR100225601B1 (ko) 항생물질 wap-8294a와 이의 제조방법 및 항균조성물
US4789731A (en) Semi-synthetic peptide antibiotics
AU648816B2 (en) Antibiotic GE1655 complex and its factors A, B and C
JP3686693B2 (ja) 新規生理活性物質ベラクチンａおよびｂとその製造法
KR0143769B1 (ko) 항균성 폴리펩티드 화합물과 그 제조방법 및 이를 함유하는 약학 조성물
JPH01168700A (ja) 新規な抗生物質

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19851204

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19891229

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19851204

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19920723

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19921030

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee